Myeloma treatment in Israel — get 3 personalized clinic matches

Professor Ron Ram practices at Sourasky Medical Center (Ichilov), Israel's largest university hospital.

• Colleague Professor Fredi Aviv heads the Bone Marrow Transplant Unit there
• The team specializes in hematologic cancers, including myeloma
• Uses advanced treatments like cellular immunotherapy
• The center leads in autologous stem cell transplantation research

Dr. Ron Ram has performed several hundred stem cell transplants at Sourasky Medical Center – a key procedure for treating Myeloma.

• Board-certified in Internal Medicine, Hematology, and Medical Oncology
• Published over 30 scientific articles and a textbook chapter on hematology
• Completed his Hematology and Oncology fellowship at New York Medical College
• Offers an individualized approach for each transplantation patient

Dr. El Hasid has conducted over 300 bone marrow and cord blood transplants for children. She leads the Pediatric Oncohematology and Oncology Department at Dana Dwek Children's Hospital.

• Specializes in pediatric bone marrow and umbilical blood transplantation
• Member of the American Association for Hematology
• Member of the Israeli Society for Pediatric Hematooncology
• Trained at the renowned City of Hope Hospital in Los Angeles
• Authored 50 publications and 40 conference reports

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.